Latest / Stock Movers / Enagas Soars, AstraZeneca Gains, Pernod Ricard Rises
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, Podcasts, radio News. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market.
- 0:13Speaker 1: Harnessing the power of Bloomberg Data.
- 0:16Speaker 2: Let's take a look at some of the stocks on
- 0:18Speaker 2: the move today in Europe. I'm Rachel Evans with Caroline Hepka,
- 0:21Speaker 2: and we're joined by Bloomberg reporter tiwa Adebio. Spanish natural
- 0:25Speaker 2: gas NAGAST has been making gains this morning. Fill us
- 0:28Speaker 2: in on what's going on there.
- 0:30Speaker 3: Well, Rachel is one of our equities reporters at Bloomberg
- 0:33Speaker 3: has put it this stock is soaring this morning, is
- 0:35Speaker 3: up as much as fifteen percent. So Anagas imports stores
- 0:40Speaker 3: and transports natural gas. They also operate plants across Spain.
- 0:44Speaker 3: And this uptick is a bit of a surprise. It
- 0:46Speaker 3: comes after the Spanish regulator unveiled a draft proposal for
- 0:51Speaker 3: gas companies, which JP Morgan is saying is unexpectedly positive.
- 0:56Speaker 3: So according to that analyst, you know, under the new proposals,
- 0:59Speaker 3: Nagas could benefit from as much as six hundred and
- 1:01Speaker 3: fifty million to seven hundred and fifty million euros of
- 1:05Speaker 3: incremental revenues. That's just in the first year, So it
- 1:08Speaker 3: really does come as a boost to the stock certainly,
- 1:12Speaker 3: emits uncertain times for importers and transporters of natural gas
- 1:17Speaker 3: like annygas. Is this conflict in the Middle East continues
- 1:20Speaker 3: to put pressure on global energy supplies. Yeah.
- 1:23Speaker 2: Absolutely. Meanwhile, a big win for Asenica after a key
- 1:28Speaker 2: breakthrough with a drug for lung disease.
- 1:32Speaker 3: That's right, So Astrozenica is near the top of the
- 1:35Speaker 3: Eurostock six hundred winners list this morning. It's up just
- 1:37Speaker 3: under four percent at the highest and the reason for
- 1:40Speaker 3: this is because of one of their experimental drugs. As
- 1:43Speaker 3: you mentioned, it's used to treat the deadly lung condition COPD,
- 1:47Speaker 3: that's chronic obstructive pulmonary disease. Now, this drug has emerged
- 1:52Speaker 3: from two separate studies now with results showing that it
- 1:56Speaker 3: brought statistically significant reductions to flare ups condition. The thinking
- 2:02Speaker 3: here from analysts surveyed by Boomberg is that this new
- 2:05Speaker 3: development could generate sales of around eight hundred and sixty
- 2:09Speaker 3: six million dollars a year by twenty thirty two. And
- 2:13Speaker 3: of course these results open up access to a broader,
- 2:17Speaker 3: more lucrative market here. But this is a particularly big
- 2:20Speaker 3: win for Astrosenica because similar products from its peers like
- 2:24Speaker 3: Sanofi and Rosch have disappointed in this area, So potentially
- 2:28Speaker 3: a first mover advantage here. But our Boomberg intelligence analysts
- 2:32Speaker 3: are warning to perhaps proceed with caution here because there
- 2:35Speaker 3: was a bit of a lack of detail in their
- 2:37Speaker 3: original statement about these results, and Astrosenica are still yet
- 2:41Speaker 3: to present this and its full findings and an upcoming
- 2:45Speaker 3: medical meeting.
- 2:46Speaker 2: Interesting, so the devil could be in the detail there. Meanwhile,
- 2:49Speaker 2: we've had some m and A newsed in the alcoholic
- 2:51Speaker 2: beverage space tell us more.
- 2:52Speaker 3: So, this still has really been the talk of the
- 2:54Speaker 3: industry as far as beverages are concerned. Over the last
- 2:57Speaker 3: two days, Perna Recard is reportedly in talks about a
- 3:01Speaker 3: potential acquisition of the owners of the firm that creates
- 3:05Speaker 3: Jack Daniel's Whiskey, That's Brown Foreman. It's a deal which
- 3:09Speaker 3: could create the second biggest player in the US market
- 3:11Speaker 3: according to analysts, so really significant. Shares up as much
- 3:15Speaker 3: as four point two percent this morning, but there are
- 3:18Speaker 3: questions from some analysts, Deutsche Bank saying they would be
- 3:21Speaker 3: surprised if the transaction actually did create material value for shareholders,
- 3:26Speaker 3: but some others, like Barclay's, saying it makes strategic sense.
- 3:30Speaker 3: So we'll definitely keep monitoring this one as those talks progress,
- 3:33Speaker 3: but certainly two very recognizable names within the setup.
- 3:37Speaker 1: The Stock Movers report from Bloomberg Radio. Check back with
- 3:42Speaker 1: us throughout the day for the latest roundup of companies
- 3:44Speaker 1: making news on Wall Street and for the latest market
- 3:47Speaker 1: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 3:52Speaker 1: Bloomberg dot com, and on Applecarplay and Android Auto with
- 3:55Speaker 1: the Bloomberg Business app.